A single dose ChAdOx1 nCoV-19 vaccine elicits high antibody responses in individuals with prior SARS-CoV-2 infection comparable to that of double dose vaccinated SARS-CoV-2 infection naïve individuals

BACKGROUND: A single dose COVID-19 vaccines, mostly mRNA-based vaccines, are shown to induce robust antibody responses in individuals who were previously infected with SARS-CoV-2, suggesting the sufficiency of a single dose to those individuals. However, these important data are limited to developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelanew, Tesfaye, Mulu, Andargachew, Abebe, Markos, Bates, Timothy A, Wassie, Liya, Tefer, Mekonnen, Fentahun, Desalegn, Alemu, Aynalem, Tamiru, Frehiwot, Assefa, Gebeyehu, Bayih, Abebe Genetu, Taffesse, Fikadu G, Mihret, Adane, Abdissa, Alemseged
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764722/
https://www.ncbi.nlm.nih.gov/pubmed/35043108
http://dx.doi.org/10.21203/rs.3.rs-1250175/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764722/
https://www.ncbi.nlm.nih.gov/pubmed/35043108
http://dx.doi.org/10.21203/rs.3.rs-1250175/v1

Ejemplares similares